Insider filings

Seer, Inc. (SEER)

NASDAQ · Healthcare · 34 insider filings · last filed 23 days ago

9
Open-market insider filings shown
1d
Median delay on the insider filings
within the two business day rule
0/9
Purchases and sales in the filings shown

About Seer, Inc.

from the company's filings and listing
Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology
Chief executive
Omid C. Farokhzad
Employees
124
Listed since
Dec 4, 2020
Market value
$106.7M
Price to earnings
-
Earnings per share
-$1.23
Dividend yield
-

seer.bio

Earnings

6 reported quarters · next on Nov 5, 2026
QuarterEPSEPS expectedRevenueRevenue expectedResult
Q2 FY2026reported Aug 11, 2026-$0.31-$0.27$3.1M$3.5MEPS missRevenue miss
Q1 FY2026reported May 13, 2026-$0.30-$0.29$2.8M$3.6MEPS missRevenue miss
Q4 FY2025reported Feb 26, 2026-$0.29-$0.32$4.2M$4.6MEPS beatRevenue miss
Q3 FY2025reported Nov 6, 2025-$0.32-$0.32$4.1M$4.6MEPS in lineRevenue miss
Q2 FY2025reported Aug 6, 2025-$0.33-$0.39$4.1M$3.8MEPS beatRevenue beat
Q1 FY2025reported May 13, 2025-$0.34-$0.37$4.2M$4.0MEPS beatRevenue beat

Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.

Executive pay

as filed for 2024 · proxy filed May 28, 2025
ExecutiveSalaryStock awardsOtherTotal
Omid Farokhzad, M.D.Chief Executive Officer$619K$937K$2.0M$3.5M
David HornPresident and Chief Financial Officer$526K$292K$610K$1.4M

The summary compensation table from the 2024 proxy statement, current executives only. 1 executive who has since left the company is named in that filing and not shown here. Read the filing

Institutional holders

13F positions as of Jun 30, 2026
HolderValueSharesChangeOf company
Softbank Group Corp.$8.5M5,135,3830.0%9.31%
Siren, L.L.C.$4.1M2,458,6730.0%4.46%
Acadian Asset Management LLC$3.2M1,953,704-5.8%3.54%
Vanguard Capital Management LLC$3.0M1,831,058-6.5%3.32%
Blackrock, Inc.$2.4M1,428,405-21.6%2.59%
Renaissance Technologies LLC$1.6M985,500+0.9%1.79%
NANO Cap New Millennium Growth Fund L P$1.4M825,0000.0%1.50%
Citadel Advisors LLC$862K519,310+100.0%0.94%
Two Sigma Investments, LP$817K492,298-3.8%0.89%
Geode Capital Management, LLC$765K460,430+8.9%0.83%
Bridgeway Capital Management, LLC$763K459,4430.0%0.83%
Peapod Lane Capital LLC$739K445,450+1.6%0.81%

A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.

Know the moment the next SEER filing lands.

GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.

Open-market insider trades

9 filings of 34 on record
InsiderActionSharesPriceValueTrade dateDelay
David R. HornPresident & CFOSold7,309$2.03$15KAug 18, 20261d
Dipchand NisharDirectorSold10,660$2.18$23KJul 8, 20262d
David R. HornPresident & CFOSold7,303$1.69$12KMay 20, 20261d
Omid FarokhzadCEO and ChairSold24,385$1.99$49KFeb 18, 20261d
David R. HornPresident & CFOSold7,743$1.99$15KFeb 18, 20261d
David R. HornPresident & CFOSold6,797$1.97$13KNov 19, 20252d
Omid FarokhzadCEO and ChairSold33,838$1.97$67KNov 19, 20252d
David R. HornPresident & CFOSold6,827$2.04$14KAug 20, 20251d
Omid FarokhzadCEO and ChairSold33,992$2.04$69KAug 20, 20251d

One row is one filing. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count.

Awards, option exercises and gifts (13)
InsiderEventSharesDate
Dipchand NisharDirectorStock award41,500Jul 28, 2026
Meeta GulyaniDirectorStock award41,500Jul 28, 2026
Terrance McguireDirectorStock award41,500Jul 28, 2026
Isaac RoDirectorStock award31,125Jul 28, 2026
Robert LangerDirectorStock award41,500Jul 28, 2026
Nicolas H. Roelofs PhDDirectorStock award41,500Jul 28, 2026
Anthony R. BazarkoChief Commercial OfficerStock award300,000May 8, 2026
Omid FarokhzadCEO and ChairStock award1,209,162Feb 3, 2026
David R. HornPresident & CFOStock award198,000Feb 3, 2026
Omid FarokhzadCEO and ChairConversion3,555,195Dec 9, 2025
Terrance McguireDirectorConversion4,088Dec 9, 2025
Isaac RoDirectorStock award102,000Sep 2, 2025
Nicolas H. Roelofs PhDDirectorStock award42,499Jul 7, 2025

Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.

Questions

Are insiders buying or selling SEER?

Across the 9 most recent open-market filings shown here, 0 were purchases and 9 were sales.

How quickly are SEER trades disclosed?

Insider filings on this page reached the public a median of 1 days after the transaction, against the two business days Form 4 allows.

How to read a Form 4

A DECISION THE INSIDER MADE

POpen-market purchase. Bought with their own money at the market price.
SOpen-market sale. Sold on the market. A sale marked scheduled was set up in advance under a Rule 10b5-1 plan, often months before.

COMPENSATION PLUMBING

AStock award. Granted as pay, not bought.
MOption exercise. Converting options already held into shares.
FTax withholding. Shares handed back to the company to pay the tax on a grant.
GGift. Given away, with no money changing hands.

Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.

Data as of Sep 10, 2026.

Related companies

also in Healthcare

See every company we track